Connect your AI

Catalyst Pharmaceutical CPRX Price / earnings

Price / earnings at other companies

PTC TherapeuticsPTCT

6.5×—

Acadia PharmaceuticalsACAD

10.1×-2.0×

Amneal Pharmaceuticals, Inc.AMRX

32.5×—

Neurocrine BiosciencesNBIX

19.8×-16.3×

TG TherapeuticsTGTX

11.5×-147×

Arrowhead ResearchARWR

44.6×—

Other financials

Income statement

Revenue$149.4M+5.6%

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

Market cap$3.84B+2.7%

Enterprise value$3.09B-4.1%

P/S6.4×-0.6×

Profitability

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

market cap/net income=13.7×

Based on the most recent quarter.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Catalyst Pharmaceutical's price / earnings?: Catalyst Pharmaceutical (CPRX) reported price / earnings of 13.7× in Q1 2026.
How has Catalyst Pharmaceutical's price / earnings changed year-over-year?: Catalyst Pharmaceutical's price / earnings decreased by 8.5% year-over-year, from 14.9× to 13.7×.
What is the long-term trend for Catalyst Pharmaceutical's price / earnings?: Over 5 years (2020 to 2025), Catalyst Pharmaceutical's price / earnings has grown at a 23.9% compound annual growth rate (CAGR), from 4.6× to 13.4×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.